Article Details
Retrieved on: 2022-09-27 20:51:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
LONDON (dpa-AFX) - AstraZeneca Plc (AZN.L, AZN) said on Tuesday that Selumetinib, sold under the brand name Koselugo, has been approved in Japan ...
Article found on: www.finanznachrichten.de
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here